{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:30:21Z","timestamp":1765456221370,"version":"3.46.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115698","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:48:22Z","timestamp":1761133702000},"page":"115698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CYLD inhibits ubiquitin-mediated degradation of IRE1 to promote inflammatory injury in ulcerative colitis"],"prefix":"10.1016","volume":"167","author":[{"given":"Jianming","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2025.115698_bb0005","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2021.08.053","article-title":"Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension","volume":"161","author":"Argmann","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.intimp.2025.115698_bb0010","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1053\/j.gastro.2022.01.023","article-title":"What does disease progression look like in ulcerative colitis, and how might it be prevented?","volume":"162","author":"Krugliak Cleveland","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2025.115698_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41573-021-00194-5","article-title":"The market for ulcerative colitis","volume":"21","author":"Al-Horani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.intimp.2025.115698_bb0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/ecco-jcc\/jjaa089","article-title":"Incidence, risk factors and outcomes of Cancer of the anal transitional zone in patients with ulcerative colitis","volume":"14","author":"Horio","year":"2020","journal-title":"J. Crohns Colitis"},{"issue":"Pt 2","key":"10.1016\/j.intimp.2025.115698_bb0025","article-title":"Analyzing the synergistic adverse effects of BPA and its substitute, BHPF, on ulcerative colitis through comparative metabolomics","volume":"287","author":"Yin","year":"2022","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.intimp.2025.115698_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J. Crohns Colitis"},{"issue":"7","key":"10.1016\/j.intimp.2025.115698_bb0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1358\/dot.2022.58.7.3408818","article-title":"Update on Ozanimod for Ulcerative Colitis","volume":"58","author":"Antonelli","year":"2022","journal-title":"Drugs of Today (Barcelona, Spain\u202f: 1998)"},{"issue":"3","key":"10.1016\/j.intimp.2025.115698_bb0040","doi-asserted-by":"crossref","DOI":"10.51894\/001c.123397","article-title":"Current pharmacologic options and emerging therapeutic approaches for the Management of Ulcerative Colitis: a narrative review","volume":"9","author":"Sebastian","year":"2024","journal-title":"Spartan medical research journal"},{"key":"10.1016\/j.intimp.2025.115698_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118437","article-title":"Comprehensive analysis of key biomarkers, immune infiltration and potential therapeutic agents for ulcerative colitis","volume":"260","author":"Lei","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.115698_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1158648","article-title":"Comprehensive analysis of endoplasmic reticulum stress-associated genes signature of ulcerative colitis","volume":"14","author":"Deng","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115698_bb0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MIB.0000000000000238","article-title":"Endoplasmic reticulum stress and unfolded protein response in inflammatory bowel disease","volume":"21","author":"Cao","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"10.1016\/j.intimp.2025.115698_bb0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2016.62","article-title":"The unfolded protein response in immunity and inflammation","volume":"16","author":"Grootjans","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115698_bb0065","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41594-019-0324-9","article-title":"UPR proteins IRE1 and PERK switch BiP from chaperone to ER stress sensor","volume":"26","author":"Kopp","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"15","key":"10.1016\/j.intimp.2025.115698_bb0070","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1080\/15384101.2018.1506655","article-title":"Regulation of IRE1 RNase activity by the ribonuclease inhibitor 1 (RNH1)","volume":"17","author":"Tavernier","year":"2018","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"6051","key":"10.1016\/j.intimp.2025.115698_bb0075","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1126\/science.1209126","article-title":"Unfolded proteins are Ire1-activating ligands that directly induce the unfolded protein response","volume":"333","author":"Gardner","year":"2011","journal-title":"Science (New York, N.Y.)"},{"issue":"6","key":"10.1016\/j.intimp.2025.115698_bb0080","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1007\/s10787-024-01527-7","article-title":"Tocilizumab unfolds Colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling","volume":"32","author":"Younes","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2025.115698_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6049500","article-title":"Endoplasmic reticulum stress in colonic mucosa of ulcerative colitis patients is mediated by PERK and IRE1 pathway activation","volume":"2022","author":"Rodrigues","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2025.115698_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.629798","article-title":"The inhibitory effect of Artesunate on excessive endoplasmic reticulum stress alleviates experimental colitis in mice","volume":"12","author":"Yin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115698_bb0095","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s10620-020-06622-7","article-title":"Inositol-requiring kinase 1 regulates apoptosis via inducing endoplasmic reticulum stress in colitis epithelial cells","volume":"66","author":"Zhang","year":"2021","journal-title":"Dig. Dis. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2025.115698_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2014.47.9.128","article-title":"Cellular ubiquitin pool dynamics and homeostasis","volume":"47","author":"Park","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.intimp.2025.115698_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.769167","article-title":"The role of E3 ubiquitin ligases and Deubiquitinases in inflammatory bowel disease: friend or foe?","volume":"12","author":"Zou","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115698_bb0110","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1080\/15548627.2021.2002101","article-title":"Inhibition of USP14 influences alphaherpesvirus proliferation by degrading viral VP16 protein via ER stress-triggered selective autophagy","volume":"18","author":"Ming","year":"2022","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.intimp.2025.115698_bb0115","first-page":"3055","article-title":"Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis","volume":"13","author":"Lin","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2025.115698_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002783","article-title":"Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response","volume":"8","author":"Perry","year":"2012","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.intimp.2025.115698_bb0125","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gutjnl-2012-303205","article-title":"Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease","volume":"63","author":"Cleynen","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2025.115698_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.655887","article-title":"Noncanonical NF-\u03baB signaling upregulation in inflammatory bowel disease patients is associated with loss of response to anti-TNF agents","volume":"12","author":"Nguyen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115698_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9238970","article-title":"Gene expression profiling of mediators associated with the inflammatory pathways in the intestinal tissue from patients with ulcerative colitis","volume":"2020","author":"Camarillo","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.intimp.2025.115698_bb0140","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41590-020-0681-x","article-title":"Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation","volume":"21","author":"Mukherjee","year":"2020","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115698_bb0145","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200169R","article-title":"SIRT1 activity orchestrates ECM expression during hESC-chondrogenic differentiation","volume":"36","author":"Smith","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2025.115698_bb0150","article-title":"Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of \u03b3\u03b4T17 cells","volume":"111","author":"Ma","year":"2023","journal-title":"Phytomedicine\u202f: international journal of phytotherapy and phytopharmacology"},{"issue":"12","key":"10.1016\/j.intimp.2025.115698_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122571","article-title":"Innovative animal model of DSS-induced ulcerative colitis in Pseudo germ-free mice","volume":"9","author":"Gancarcikova","year":"2020","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.intimp.2025.115698_bb0160","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1042\/BCJ20200919","article-title":"Structural and molecular bases to IRE1 activity modulation","volume":"478","author":"Langlais","year":"2021","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.intimp.2025.115698_bb0165","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s12079-023-00784-5","article-title":"Dual RNase activity of IRE1 as a target for anticancer therapies","volume":"17","author":"Bartoszewska","year":"2023","journal-title":"J Cell Commun and signaling"},{"key":"10.1016\/j.intimp.2025.115698_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.697360","article-title":"Regulation of endoplasmic reticulum stress-autophagy: a potential therapeutic target for ulcerative colitis","volume":"12","author":"Qiao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115698_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-024-01527-7","article-title":"Tocilizumab unfolds Colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling","author":"Younes","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1016\/j.intimp.2025.115698_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025589","article-title":"Involvement of endoplasmic reticulum stress in inflammatory bowel disease: a different implication for colonic and ileal disease?","volume":"6","author":"Bogaert","year":"2011","journal-title":"PLoS One"},{"issue":"44","key":"10.1016\/j.intimp.2025.115698_bb0185","doi-asserted-by":"crossref","first-page":"30567","DOI":"10.1074\/jbc.M114.562868","article-title":"Ubiquitination of inositol-requiring enzyme 1 (IRE1) by the E3 ligase CHIP mediates the IRE1\/TRAF2\/JNK pathway","volume":"289","author":"Zhu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.115698_bb0190","doi-asserted-by":"crossref","unstructured":"Hromas R, Srinivasan G, Yang M, Jaiswal A, Totterdale TA, Phillips L, Kirby A et al: BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1. iScience 2022, 25(12):105626.doi: https:\/\/doi.org\/10.1016\/j.isci.2022.105626.","DOI":"10.1016\/j.isci.2022.105626"},{"issue":"3","key":"10.1016\/j.intimp.2025.115698_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response","volume":"297","author":"Snyder","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.115698_bb0200","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.molmed.2022.01.006","article-title":"Ubiquitin-modifying enzymes as regulators of colitis","volume":"28","author":"Ruan","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115698_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152026","article-title":"Roles of protein ubiquitination in inflammatory bowel disease","volume":"225","author":"Xiao","year":"2020","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.intimp.2025.115698_bb0210","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050093","article-title":"CYLD in health and disease","volume":"16","author":"Mar\u00edn-Rubio","year":"2023","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"10.1016\/j.intimp.2025.115698_bb0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.2012.01100.x","article-title":"Regulation of NF-\u03baB by deubiquitinases","volume":"246","author":"Harhaj","year":"2012","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2025.115698_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020199","article-title":"Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays","volume":"2","author":"Costello","year":"2005","journal-title":"PLoS Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.115698_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024106","article-title":"Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review","volume":"6","author":"Cleynen","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2025.115698_bb0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.gastro.2018.10.023","article-title":"Alternative splice forms of CYLD mediate ubiquitination of SMAD7 to prevent TGFB signaling and promote colitis","volume":"156","author":"Tang","year":"2019","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.intimp.2025.115698_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111864","article-title":"CYLD deubiquitinates plakoglobin to promote Cx43 membrane targeting and gap junction assembly in the heart","volume":"41","author":"Xie","year":"2022","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.intimp.2025.115698_bb0240","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.molcel.2025.02.021","article-title":"UbiREAD deciphers proteasomal degradation code of homotypic and branched K48 and K63 ubiquitin chains","volume":"85","author":"Kiss","year":"2025","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.intimp.2025.115698_bb0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","article-title":"The unfolded protein response and cell fate control","volume":"69","author":"Hetz","year":"2018","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.intimp.2025.115698_bb0250","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41419-024-06663-0","article-title":"IRE1 signaling increases PERK expression during chronic ER stress","volume":"15","author":"Ong","year":"2024","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.intimp.2025.115698_bb0255","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41589-020-0584-z","article-title":"Pharmacologic IRE1\/XBP1s activation confers targeted ER proteostasis reprogramming","volume":"16","author":"Grandjean","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115698_bb0260","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41467-022-28271-2","article-title":"Pharmacologic IRE1\/XBP1s activation promotes systemic adaptive remodeling in obesity","volume":"13","author":"Madhavan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115698_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116569","article-title":"The IRE1 signaling pathway is involved in the protective effect of low-dose LPS on myocardial ischemia-reperfusion injury","volume":"231","author":"Wu","year":"2019","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115698_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107169","article-title":"Exploring the IRE1 interactome: from canonical signaling functions to unexpected roles","volume":"300","author":"Le Goupil","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.115698_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2019.12.049","article-title":"Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-\u03baB signaling","volume":"524","author":"Yamanaka","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115698_bb0280","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12943-024-02140-6","article-title":"Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation","volume":"23","author":"Guo","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925016893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:27:44Z","timestamp":1765456064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925016893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"alternative-id":["S1567576925016893"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115698","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYLD inhibits ubiquitin-mediated degradation of IRE1 to promote inflammatory injury in ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115698"}}